👀 CONFLICTS OF INTEREST in Australian Vaccination Policies
Dr Katie ATTWELL
Member of Immunisation Coalition (01) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (02).
Part of a team conducting an evaluation of the “I Immunise” campaign, funded through an unrestricted grant from vaccine manufacturer Sanofi-Pasteur(03)
Prof Kristine MACARTNEY
$65,330,038 in government grants covering 2020-2023.
Yes: 65 MILLION DOLLARS IN GRANTS TO MACARTNEY.
She is also a member of the Advisory Committee on vaccines (ACV) of the Therapeutic Goods Administration (TGA). Prof Kristine Macartney has also acted as an expert consultant to the World Health Organisation (WHO).
She was also one of the contributing authors of a peer-reviewed paper entitled “Constructing an ethical framework for priority allocation of pandemic vaccines.” Read paper here: https://doi.org/10.1016/j.vaccine.2020.12.053
Prof Kristine Macartney was chosen to represent the government in the NSW Supreme Court hearings.
Director of National Centre for Immunisation Reseasrch & Surveillance (NCIRS) (04)
Presentation at “International Vaccine conference”, where travel was sponsored (05)
In 2018, member of ATAGI’s “Influenza Working Party” which prepares advice for ATAGI (07)
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia (08)
Member of ATAGI’s “HPV working Party” which prepare advice on the epidemiology of HPV and potential vaccination strategies in Australia (09)
Member of ATAGI’s COVID-19 Working Group (10) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Prof Ian BARR
Member of Immunisation Coalition(11), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (12)
Deputy Director of the WHOCollaborating Centre for Reference and Research on Influenza at the Doherty Institute, where he has had over 35 years’ experience in biological research and development in academic institutions and at CSL on various topics such as vaccine development (13)
From 2015 to 2016 and in 2007, was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines (14)
Former President of the Australian Medical Association (15) (resigned late 2020 after 2 years).
Member of Immunisation Coalition (16), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (17).
A/Prof Christopher BLYTH
Investigator on a pneumonia/meningitis study in Papua New Guinea. Grant received by employer (The University of Western Australia) from Pfizer (18)
Co-Director of Wesfarmers Centre for Vaccines and Infectious Diseases; Telethon Kids (19), which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi(20)
Co-Chair of ATAGI’s COVID-19 Working Group (21) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Co-Chair of Australian Technical Advisory Group on Immunisation (ATAGI). (22)
Member of COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Board (23)
Medical Advisor of Meningococcal Australia(24), which has received funds from vaccine manufacturers GSK and Pfizer (25)
Was Head of Clinical Research at the National Centre for Immunisation Research & Surveillance 2005 to 2019 (26)
Previously Chair, currently Director and Scientific Advisory Member of the Immunisation Coalition (27) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (28).
In 2009, Robert Booy was a co-author of an “Influenza Vaccine trial” which was funded by CSL(29)
He received funding from CSL, Roche, Sanofi Pasteur, GSK and Pfizer to conduct research or attend and present at scientific meetings (30)
Member of Friends of Science in Medicine (31), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (32)
Co-Author of the Department of Health’s report “Planning for human papillomavirus vaccines in Australia”. This is the report of a meeting convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 12 December 2003, bringing together representatives from eight Australian research groups involved in HPV research, and vaccine manufacturers with HPV vaccine candidates. The meeting was supported by vaccine manufacturers CSL Pharmaceuticals and Glaxo SmithKline(33)
Prof Allen CHENG
Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health (34), which has received payments from vaccine manufactureres Biocryst, George Clinical, Gilead, GSK and Merck (35), and has an appointment in the School of Public Health and Preventive Medicine at Monash University (36).
Member of the COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Group (38)
Co-Chair of ATAGI’s COVID-19 Working Group (39) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Deputy Chief Health Officer of Victoria (40) and influential on coronavirus policy.
Therapeutic Goods Administration (TGA) Advisory Committee on infectious diseases and biostatistics (41)
Site Investigator for a number of infectious disease studies via Alfred Health, which has received payments from vaccine manufacturers Biocryst, George Clinical, Gilead, GSK and Merck (42)
Chief Investigator for influenza surveillance (FluCAN Surveillance System) (43)
In 2018 Chair of the Influenza Working Party which prepares advice for ATAGI (44)
His team has recently received $1.7M from federal governments National Health & Medical Research Council (NHMRC), Refer to NHMRC section below for COI, towards research into how influenza virus infection results in severe illness and death in Australia (45)
Chairman of the Board of Guardians of the Future Fund (46), an Australian government investment fund, with over 2 billion dollars worth of shares in pharmaceutical and vaccine manufacturers i.e. CSL, Johnson and Johnson, Pfizer, Novartis and Merck (47). The Future Funds investment in pharmaceutical and vaccine manufacturers has doubled from $1 billion to $2 billion during the coronavirus situation.
Non-Executive Chairman of Nine Entertainment Co. (48)
Nine Entertainment own newspapers “the Sydney Morning Herald” and “The Sun Herald” (49), who were/are instrumental in “anti-vax” labelling (50).
A/Prof Nigel CRAWFORD
Currently Director of Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) at Murdoch Children’s Research Institute (51), which has received funding from Vaccination and Immunisation Research Group from Novartis Vaccines, GSK and Sanofi (52) & (53)
Member of ATAGI’s COVID-19 Working Group (55) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Previously Director of The Influenza Specialist Group (56), which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi (57).
Member of Immunisation Coalition (58), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (59).
Group Leader of Vaccine Updake at Murdoch Children’s Research Institute (MCRI)(60)
She is also promoting COVID-19 vaccination amongst elderly and children (61).
Laureate Prof Peter DOHERTY
The Doherty Institute for Infection & Immunity is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize (62) , where Peter Doherty is still active in science and involved in large, grant-funded programs at both institutions, he commutes between St Jude Children’s Research Hospital in Memphis and the Doherty Institute where he now spends most of his time (63).
The Peter Doherty Institute is also in collaboration with Vaccine and Immunisation Research Group/Murdoch Children’s Research Institute (64) which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris (65).
The Peter Doherty Institute have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19 (66).
Peter Doherty is a member of Friends of Science in Medicine (67), which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (68)
In the last 10 years has been involved in research projects awarded in excess of AU$30 million, includes grants from NHMRC and Bill and Melinda Gates Foundation (70).
Former member of Influenza Vaccine Advisory Board, travel paid for by vaccine manufacturers Sanofi and Seqirus (71)
Member of ATAGI’s COVID-19 Working Group (72) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Presenter at a number of conferences in clinical infectious diseases sponsored by vaccine manufacturer Pfizer (73)
Former member of a number of vaccine advisory boards for the influenza vaccine (74)
Co-Inventor of Gardasil vaccine against HPV, (patent with vaccine manufacturer CSL and The University of QLD) (75) and he receives royalties from HPV vaccine sales in the developed world (76)
Member of Friends of Science in Medicine (77) , which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 (78)
Jane HALTON
Adviser to Prime Minister Scott Morrison on the government’s National COVID-19 Coordination Commission(79)
She is Chair of the Coalition for Epidemic Preparedness Innovations (CEPI) (80) , which has funded $388M to COVID-19 vaccine manufacturer Novavax (81) which is being trialled in Australia (82)
She is pushing for COVID “No Jab, No Play” policy to be adapted to adults (83)
She is Director of Crown Resorts (84) , which is the COVID-19 quarantine facility in Victoria (85)
Her husband, Trevor Sutton, was the Deputy for Australian Statistician of the Australian Bureau of Statistics (ABS) and sits on the advisory committee of Institute for Health Metrics & Evaluation (IHME) (86) of which Jane Halton sits on the board (87) . In 2007, the IHME received funding from Bill & Melinda Gates Foundation(88)
In 2016, The ABS’s data collection and survey systems was awarded to Accenture (89) , which is in direct partnership with ID2020 agenda and GAVI (90).
Collaborates with WHO Influenza and Essential Regulatory Laboratories (98)
CEO of National Health & Medical Research Council (99)
From 2007 to 2015 was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines (100) .
Had an undisclosed number of shares in vaccine manufacturer CSL where she claimed she bought well before 2007 (101)
In 2009, she helped draw up Australia’s response to the swine flu outbreak (102). CSL was given a $131 million federal government contract to produce the nation’s entire stockpile of swine flu vaccine in 2009 (103).
Current President of the Australian Medical Association (104).
The AMA is affiliated with the Immunisation Coalition (105), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google (106).
Omar has stated “vaccinating the whole of the population is the only way “to survive” coronavirus coming to our shores”.(107).
Dr Stephen Bernard LAMBERT
Chair of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance (108).
Has been involved in influenza and pertussis safety studies where he received grants from Sanofi and Seqirus (109).
Prof Helen MARSHALL
ATAGI member at the time, Helen Marshall was also Lead Investigator on a GlaxoSmithKline funded Bexsero meningococcal B vaccine trial in South Australia (110) & (111)
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance(112).
Researcher on clinical trials funded by vaccine manufacturer GSK, Novartis, Pfizer, Merck, Novovax, and Sanofi(113)(114).
Member of Friends of Science in Medicine(115), which supported “No Jab, No Pay” bill at the Senate Hearing in Nov 2015 (116)
Former Director of National Centre for Immunisation Reseasrch & Surveillance 2005 to 2017 (117)
Ex-officio member of ATAGI from 1999-2017 and from 2005 to 2017 National Immunisation Committee (responsible for implementation of immunisation programs) (118).
Member of ATAGI’s “Pertussis Working Party” which prepared advice on the epidemiology of pertussis and potential vaccination strategies in Australia (119)
In 2018 Member of the “Influenza Working Party” which prepared advice for ATAGI (120)
In 2003, Prof McIntyre was involved with the inception of HPV vaccination in Australia. He was instrumental in coordinating the meeting with Julia Brotherton which was funded by vaccine manufacturers GSK and CSL(121)
The ATAGI Declarations of Interest document from 2015 states that Prof McIntyre has been associated with grant funding from GSK, Pfizer, Merck, National Health & Medical Research Council and ARC (122)
In 2018 Member of the “Influenza Working Party” which prepares advice for ATAGI(123)
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia (124)
Director of Influenza Specialist Group (125) which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi (126).
Received funding from the Australian Research Council (ARC) for vaccine clinical trial investigations (127)
Travel covered to attend a number of workshops and symposiums sponsored by vaccine companies(128)
Investigator on clinical trials funded by vaccine manufacturers GlaxoSmithKline, bioCSL, Novartis and Pfizer (129).
Member of Asia-Pacific Alliance for the Control of Influenza (APACI)(130) ], which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL (131)
Jodie McVernon is currenty part of the Peter Doherty Institute for Infection & Immunity, COVID-19 Research team (132).
Member of ATAGI’s COVID-19 Working Group (133) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Currently Head of Vaccination and Immunisation Research Group (VIRGo), which he established in the 1990’s [57] at the Murdoch Children’s Research Institute, which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris (134).
In 2005 to 2014, Terry Nolan was appointed Chair of the Australian Technical Advisory Group on Immunisation (ATAGI) (135).
He was also appointed deputy-chair of the National Health and Medical Research Council for over 9 years (136) which decides the area of government research that should be funded (137).
In 2009 (during his employment with ATAGI (138), Terry Nolan was the Lead Author on CSL’s funded Panvax (mono-valent H1N1) Influenza vaccine, trialled on 400 children (139)
He was also on the CSL Limited vaccine advisory board (140)
In 2010, CSL’s Fluvax (tri-valent) Influenza vaccine was suspended for its use on children 6 months to 5 years due to its increase of febrile reactions following vaccination (141). The government inquiry was led by Terry Nolan and Peter Richmond (142)] who were both on CSL’s advisory board(143). CSL was given a $131 million federal government contract to produce the nation’s entire stockpile of swine flu vaccine in 2009, half of which had to be destroyed when it passed its use-by date (144)
Terry Nolan has served on a data safety monitoring board for GSK for the HPV vaccine and GSK advisory boards (unpaid) for pertussis vaccine (2014 and 2016) (145).
Contributor of the World Health Organisation (WHO), Scientific Advisory Group of Experts (SAGE) meetings on evaluation of pandemic influenza vaccines in clinical trials each year from 2006-2011 [60].
Terry Nolan is currently part of the Peter Doherty Institute for Infection & Immunity, COVID-19 Research team (146).
In 2010, Terry Nolan published a report “The Australian model of immunization advice and vaccine funding”, where he states that industry sponsored vaccines are generally not considered a conflict requiring exclusion (147)
Chairman of the Immunisation Coalition (148) , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (149).
Member of the Asia-Pacific Alliance for the Control of Influenza (APACI) (150) which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL(151)
Member of the Working Group on a GlaxoSmithKline funded Bexsero meningococcal B vaccine trial in South Australia (152)
Prof Peter RICHMOND
Head, Vaccine Trials Group of Telethon Kids (153), which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi (154).
A member of the Influenza Specialist Group (155) , a government body which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi (156).
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance(157)
Was Deputy Chair of ATAGI on Immunisation 2006 to 2004 (158).
Was Chair of ATAGI “MMR Varicella and Zoster Vaccine working Party”, 2006-2014 (159)
Member of Immunisation Coalition (160), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (161)
Has been a representative on a CSL vaccine advisory board at various times and has received nominal payments from vaccine manufacturer CSL (honoraria) (162)
Was also an investigator on the CSL funded clinical trial for Panvax vaccine in 2009 (163)
As at 2019, Chair of WA Immunisation Scentific Advisory Group (164) and Chair of WA Vaccine Safety Advisory Committee(165)
He was co-author of the Western Australian Influenza Vaccine Efficacy trial (WAIVE) for children in WA (2008 –2015) (166) which at the time was funded by vaccine manufacturers CSL, Sanofi–Pasteur and WA Health Dept in 2008 (announced by Government of Western Australia, Department of Health, Media Release 15th Feb 2008, Free vaccines to help fight child influenza – which is no longer available). However, WAVE trial is currently with Telethon Kids(167), which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi (168).
Served on scientific advisory boards for Sanofi (influenza vaccine), GSK (maternal immunisation), AstraZeneca (influenza vaccine) (169).
Served on vaccine scentific advisory groups for GlaxsoSmith Kline (pertussis), Pfizer (pneumococcal conjugate vaccines), Baxter (mengingococcal C conjugate & ross river virus vaccine) and Murdoch Children’s Research Institute (rotavirus RV3 D5MB) (170)
Principal Investigator of industry sponsored multi-centre studies for Baxter, CSL, GlaxsoSmithKline, Medimmune, Merck, Pfizer, Sanofi and Novartis(171)
Received research funding for investigator initiated studies from GlaxoSmithKline, Merck, and Novartis(172)
Chairperson of the Council of National Health & Medical Research Council (NHMRC) (173) , who was formerly on the Advisory Board for AstraZeneca and Bayer Australia(174). The Immunisation Handbook is approved NHMRC(175)
Kim SAMPSON
CEO of the Immunisation Coalition (176), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (177)
Executive Director of the Asia-Pacific Alliance for the Control of Influenza (APACI)(178) which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL(179)
Dr Tom SNELLING
Member of PBS/PBAC (180), which receives funds from Cost Recovery Fees & Charges from vaccine manufacturers (181).
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance (183).
Head, Infectious Disease Implementation at Telethon Kids(184), which is partnered with vaccine manufacturers GSK, Johnson & Johnson, Novartis, Pfizer, Roche, and Sanofi (185)
Former investigator on pneumococcal vaccine for the National Immunisation Program (186)
Member of ATAGI’s COVID-19 Working Group (188) which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Member of the Immunisation Coalition(189), which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google (190)
In January 2020 he expressed “pushing anti-vax views should be criminal offence” (191).
Doherty Institute, Ian Barr: https://www.doherty.edu.au/people/dr-ian-barr “35 years experience in biological research and development in academic institutions and at ACSL on various topics such as vaccine development
Paul Van Buynder speaks out against anit-vaxxers: PDF
Penny... on Health
Penny... on Health
DISCLAIMER: The information on this website is not medical science or medical advice. I do not have any medical training aside from my own research and interest in this area. The information I publish is not intended to diagnose, treat, cure or prevent any disease, disorder, pain, injury, deformity, or physical or mental condition. I just report my own results, understanding & research.
![[Rennick] COVID-19 Vaccination Status (Prevention of Discrimination) Bill](https://cidrgzrcl3d7.cdn.shift8web.ca/wp-content/uploads/2021/11/rennick-shockingmedicalinjuries-777x437.jpg)
